Results 1 - 20 of 141,095 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (133,672)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
A Monoclonal Antibody for Malaria PreventionThe New England journal of medicine, 2021-08, Vol.385 (9), p.803-814 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034031 ;PMID: 34379916Full text available |
| 2 |
Material Type: Article
|
|
Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional propertiesmAbs, 2013-01, Vol.5 (1), p.22-33 [Peer Reviewed Journal]Copyright © 2013 Landes Bioscience 2013 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.4161/mabs.22771 ;PMID: 23211638Full text available |
| 3 |
Material Type: Article
|
|
Lecanemab in Early Alzheimer’s DiseaseThe New England journal of medicine, 2023-01, Vol.388 (1), p.9-21 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212948 ;PMID: 36449413Full text available |
| 4 |
Material Type: Article
|
|
Strategies and challenges for the next generation of antibody-drug conjugatesNature reviews. Drug discovery, 2017-05, Vol.16 (5), p.315-337 [Peer Reviewed Journal]Copyright Nature Publishing Group May 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.268 ;PMID: 28303026Full text available |
| 5 |
Material Type: Article
|
|
Neutrophils mediate antibody-induced antitumor effects in miceBlood, 2013-10, Vol.122 (18), p.3160-3164 [Peer Reviewed Journal]2013 American Society of Hematology ;Distributed under a Creative Commons Attribution 4.0 International License ;2013 by The American Society of Hematology 2013 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2013-04-497446 ;PMID: 23980063Full text available |
| 6 |
Material Type: Article
|
|
Evinacumab in Patients with Refractory HypercholesterolemiaThe New England journal of medicine, 2020-12, Vol.383 (24), p.2307-2319 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2031049 ;PMID: 33196153Full text available |
| 7 |
Material Type: Article
|
|
Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: A randomized, double-blind, placebo-controlled studyJournal of clinical pharmacology, 2014-02, Vol.54 (2), p.168-178 [Peer Reviewed Journal]2013, The American College of Clinical Pharmacology ;2014 American College of Clinical Pharmacology ;2013, The American College of Clinical Pharmacology. ;ISSN: 0091-2700 ;EISSN: 1552-4604 ;DOI: 10.1002/jcph.239 ;PMID: 24272917Full text available |
| 8 |
Material Type: Article
|
|
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque PsoriasisThe New England journal of medicine, 2012-03, Vol.366 (13), p.1190-1199 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1109997 ;PMID: 22455413 ;CODEN: NEJMAGFull text available |
| 9 |
Material Type: Article
|
|
Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic PotentialPloS one, 2015-09, Vol.10 (9), p.e0137345 [Peer Reviewed Journal]COPYRIGHT 2015 Public Library of Science ;2015 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Liu et al 2015 Liu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0137345 ;PMID: 26390038Full text available |
| 10 |
Material Type: Article
|
|
Particle shape enhances specificity of antibody-displaying nanoparticlesProceedings of the National Academy of Sciences - PNAS, 2013-02, Vol.110 (9), p.3270-3275 [Peer Reviewed Journal]copyright © 1993-2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Feb 26, 2013 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1216893110 ;PMID: 23401509Full text available |
| 11 |
Material Type: Article
|
|
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction AdenocarcinomaClinical cancer research, 2020-02, Vol.26 (4), p.846-854 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-2443 ;PMID: 31676670Full text available |
| 12 |
Material Type: Article
|
|
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agentProceedings of the National Academy of Sciences - PNAS, 2013-08, Vol.110 (32), p.E2987-E2996 [Peer Reviewed Journal]Copyright National Academy of Sciences Aug 6, 2013 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1302725110 ;PMID: 23882082Full text available |
| 13 |
Material Type: Article
|
|
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trialBritish journal of dermatology (1951), 2015-10, Vol.173 (4), p.930-939 [Peer Reviewed Journal]2015 The Authors. published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. ;2015 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. ;Copyright © 2015 British Association of Dermatologists ;ISSN: 0007-0963 ;EISSN: 1365-2133 ;DOI: 10.1111/bjd.13932 ;PMID: 26042589Full text available |
| 14 |
Material Type: Article
|
|
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic reviewCochrane database of systematic reviews, 2021-03, Vol.2021 (3), p.CD013881 [Peer Reviewed Journal]Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD013881 ;PMID: 33734435Full text available |
| 15 |
Material Type: Article
|
|
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaThe New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035716 ;PMID: 33616314Full text available |
| 16 |
Material Type: Article
|
|
Phage Display Technology as a Powerful Platform for Antibody Drug DiscoveryViruses, 2021-01, Vol.13 (2), p.178 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v13020178 ;PMID: 33504115Full text available |
| 17 |
Material Type: Article
|
|
Cemiplimab: First Global ApprovalDrugs (New York, N.Y.), 2018-11, Vol.78 (17), p.1841-1846 [Peer Reviewed Journal]Springer Nature Switzerland AG 2018 ;Copyright Springer Science & Business Media Nov 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-1012-5 ;PMID: 30456447Full text available |
| 18 |
Material Type: Article
|
|
Galcanezumab: First Global ApprovalDrugs (New York, N.Y.), 2018-11, Vol.78 (16), p.1769-1775 [Peer Reviewed Journal]Springer Nature Switzerland AG 2018 ;Copyright Springer Science & Business Media Nov 2018 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-018-1002-7 ;PMID: 30378008Full text available |
| 19 |
Material Type: Article
|
|
Dostarlimab for Primary Advanced or Recurrent Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026Full text available |
| 20 |
Material Type: Article
|
|
Obinutuzumab: First Global ApprovalDrugs (New York, N.Y.), 2014, Vol.74 (1), p.147-154 [Peer Reviewed Journal]Springer International Publishing Switzerland 2013 ;2015 INIST-CNRS ;Copyright Wolters Kluwer Health Adis International Jan 2014 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-013-0167-3 ;PMID: 24338113 ;CODEN: DRUGAYFull text available |
Results 1 - 20 of 141,095 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (133,672)
Refine My Results
Creation Date
- Before 1985 (6,673)
- 1985 To 1993 (36,132)
- 1994 To 2002 (30,502)
- 2003 To 2012 (34,215)
- After 2012 (33,577)
-
More options
New Records
- New From Last Week (11)
- New From Last Month (116)
- New From Last 3 Month (482)
-
More options
Resource Type
- Articles (140,870)
- magazinearticle (76)
- Thesises (postgraduate) (40)
- Conference Proceedings (36)
- Web Resources (35)
- Books (15)
- Book Chapters (13)
- Reports (6)
- Text Resources (2)
- Newsletter Articles (1)
- Reviews (1)
-
More options
Subject
- Science & Technology (116,580)
- Life Sciences & Biomedicine (111,318)
- Humans (101,448)
- Animals (62,569)
- Biological And Medical Sciences (54,079)
- Female (43,900)
- Mice (37,610)
- Antibodies, Monoclonal (35,830)
- Antibodies, Monoclonal - Immunology (35,542)
- Male (35,274)
- Medical Sciences (27,862)
- Fundamental And Applied Biological Sciences. Psychology (27,774)
- Immunology (27,718)
- Antibodies, Monoclonal - Therapeutic Use (23,951)
- Middle Aged (22,218)
- Adult (20,654)
- Oncology (20,013)
- Monoclonal Antibodies (18,590)
- Aged (16,414)
- Biochemistry & Molecular Biology (14,578)
-
More options
Databases
- MEDLINE (140,460)
- GFMER Free Medical Journals (61,270)
- ProQuest Central (44,546)
- Open Access: PubMed Central (40,502)
- HighWire Press (Free Journals) (37,368)
- DOAJ Directory of Open Access Journals (20,964)
- Open Access: Wiley-Blackwell Open Access Journals (11,895)
- ROAD: Directory of Open Access Scholarly Resources (11,516)
- Springer Open Access Journals (5,883)
- IngentaConnect Open Access (5,462)
- Open Access: Nature Open Access (3,622)
- ProQuest One Psychology (3,621)
- JSTOR Early Journal Content (2,954)
- Taylor & Francis (Open access) (1,874)
- PLoS (Open access) (1,765)
- Freely Accessible Japanese Titles - check A-Z of ejournals (1,559)
- Open Access: Freely Accessible Journals by multiple vendors (1,375)
- Journals@Ovid Open Access Journal Collection Rolling (1,140)
- Mary Ann Liebert Online - Open Access (1,009)
- Open Access: Cell Press Free Archives (997)
-
More options
Language
Journal Title
- Blood (2,972)
- Cancer Research (2,277)
- Clinical Cancer Research (1,575)
- Infection And Immunity (1,550)
- Journal Of Immunological Methods (1,703)
- Journal Of Virology (1,758)
- Plos One (1,498)
- Proceedings Of The National Academy Of Sciences - Pnas (2,168)
- The Journal Of Biological Chemistry (2,627)
- The Journal Of Immunology (5,653)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||